Teva CEO responds to 25% share worth fall
Since publishing its monetary outcomes for 2024 on the finish of January, the share worth of Teva Pharmaceutical Industries ...
Tag: Teva
Teva jumps sharply on bowel illness drug outcomes
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA share worth opened 20% greater on Wall Road after the Israeli ...
Teva experiences sturdy Q2 outcomes, raises 2024 forecast
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) reported sturdy outcomes for the second quarter of 2024 and once ...
Teva loss narrows as income grows
Because the US generics market recovers Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) ended the primary quarter of ...
